Atlas Trials

Trial Evaluating Gleevec in Patients With Anaplastic Thyroid Carcinoma

Clinical trial NCT00115739 · TERMINATED

Trial details

NCT number
NCT00115739
Sponsor
University of Michigan Rogel Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Thyroid Cancer
Start date
2004-02-01
Primary completion
2008-05-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.